Ally Bridge Group
Private Equity Venture Capital Est. 2013
Also known as AB, Ally.
USD 2B
Estimated FUM
- Type
- Private Equity
- HQ
- Hong Kong Island, Hong Kong
- Founded
- 2013
- Focus
- Healthcare
About
Ally Bridge Group is a life-sciences investment firm active in private and public markets. Its private-equity strategy makes last-mile life-sciences investments, while long/short and long-only public-equity strategies invest primarily in listed biotechnology.
Strategies
Buyout
Growth Equity
Venture Capital
Public Equity
Focused strategy
Investment Focus
Across the firm
Sources
- investormatch.pro — Life Sciences
- ally-bridge.com — Healthcare & Life Sciences
Capital & location details · updated 2026-10-13
Locations & investment markets
Recorded venture investment · Thousand Oaks, United States · 2013-11-07
ImmunGene
The dated release identifies ImmunGene in Thousand Oaks, California and says its Series A financing was from Ally Bridge Group. This is a historical observed investment, not a current investment mandate.
Investment Criteria
Investment size
USD 7M - USD 100M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Investment Stages
Stages
Growth Series A Series B
Investment Geographies
Primary Markets
Hong Kong United States
Coverage
Global Regions
Asia North America
Coverage is a guide only.
Location
Headquarters
Hong Kong Island, Hong Kong
Office Presence
2 countries
Hong Kong United States
2 known offices
Hong Kong Island, Hong Kong (HQ)
Boston, MA, United States
People also viewed
Lightyear Capital
Lightyear Capital is a private equity firm focused on investing in financial services in the United States. We have deep expertise in the sector, having been investing since 2000 across multiple market cycles and environments. We invest in all areas of financial services including asset management, banking, brokerage, payments, insurance and speciality finance. We offer substantial operational, transactional and regulatory support to our investee companies.
Revelar Capital
Revelar Capital, known as Wellspring Capital Management until October 2025, is a New York private equity firm that partners with North America-based, middle-market businesses. It invests exclusively in healthcare services, business services and specialty manufacturing.
Eight Roads
Eight Roads is a Fidelity-backed global investment platform with venture teams investing in technology and healthcare companies across Asia, Europe, Israel and the US.
Bain Capital Ventures
Bain Capital Ventures is a venture capital fund focused on high-growth enterprise software opportunities, including SaaS, data services, marketing-tech, fin-tech, healthcare and software. We partner with great B2B founders and accelerate their market vision. Our investments span $1 million seed capital through to $100m growth equity cheques. We draw on a global network of experience, and the full resources of Bain Capital, one of the world's leading alternative asset firms with more than $60 billion under management across a variety of investment strategies.
Our focus areas currently include business applications (DocuSign, SendGrid, Gainsight), infrastructure and security (Redis Labs, Rubrik, Armis), financial technology (Acorns, IEX), healthcare IT (AbleTo, ABILITY Network), and consumer (Rent the Runway, Jet). We also have emerging practices in autonomy/mobility (Ike, Lime) and cryptocurrency (DCG, Compound Labs).
Bain Capital Ventures invests globally, although the majority of our investments are in the United States
EQT Partners
EQT Partners is a global alternative investment firm with strategies across private equity, infrastructure, real estate, growth equity, and public value.
Highland Capital Partners
Highland Capital Partners is a venture capital firm founded in 1988, focusing on early-stage investments in technology and healthcare companies.